Health Monitor Liechtenstein: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Monitor Liechtenstein.

Press releases published on March 18, 2026

Mar. 18, 2026

60 Degrees Pharmaceuticals Files New Dietary Ingredient Notification (NDIN) with FDA for Australian Chestnut Extract

Indeterminate GlobeNewswire

Mar. 18, 2026

OXB enters into licensing agreement with Viral Vector Manufacturing Facility (VVMF), providing access to its AAV and LV viral vector platforms

Indeterminate GlobeNewswire

Mar. 18, 2026

Amphista Therapeutics appoints Louise Modis Ph.D. as CEO and Patrick Kelly M.D. as CMO and provides a business update as the Company prepares to file IND application for AMX-883

Indeterminate GlobeNewswire

Mar. 18, 2026

Lice Clinics of America Opens New Head Lice Treatment Clinic in Ramsey, New Jersey

Indeterminate GlobeNewswire

Mar. 18, 2026

JenaValve Announces FDA Approval of the Trilogy™ Transcatheter Heart Valve System — the First and Only Transcatheter Device Approved for Symptomatic, Severe Aortic Regurgitation (ssAR) in the United States

Indeterminate GlobeNewswire

Mar. 18, 2026

Nautilus Biotechnology Announces Baylor College of Medicine as First Early Access Program Customer for Voyager Platform

Indeterminate GlobeNewswire

Mar. 18, 2026

Messino Cancer Centers Opens New Asheville Clinic

Indeterminate GlobeNewswire

Mar. 18, 2026

Celcuity Schedules Release of Fourth Quarter and Full Year 2025 Financial Results and Webcast/Conference Call

Indeterminate GlobeNewswire

Mar. 18, 2026

Curanex Achieves Key Preclinical Milestone with Favorable Toxicology Profile at Maximum Dose, Advancing Toward IND Submission

Indeterminate GlobeNewswire

Mar. 18, 2026

Arcutis to Present New Clinical Data in a Late-Breaking Podium Presentation and Scientific Posters at the 2026 American Academy of Dermatology Annual Meeting

Indeterminate GlobeNewswire

Mar. 18, 2026

Corbus Pharmaceuticals to Participate in the BMO 2026 Metabolic Health Summit

Indeterminate GlobeNewswire

Mar. 18, 2026

Alumis Announces Late-Breaker Oral Presentation of Phase 3 Data for Envudeucitinib in Moderate-to-Severe Plaque Psoriasis at 2026 American Academy of Dermatology Annual Meeting

Indeterminate GlobeNewswire

Mar. 18, 2026

Cingulate Inc. Reports Fourth Quarter and Full Year 2025 Financial Results and Operational Highlights

Indeterminate GlobeNewswire

Mar. 18, 2026

Lifeward Reports Fourth Quarter and Full Year 2025 Financial Results

Indeterminate GlobeNewswire

Mar. 18, 2026

Viral Vector Manufacturing (VVMF) enters into licensing agreement with OXB, gaining access to the OXB AAV and LV viral vector platforms

Indeterminate GlobeNewswire

Mar. 18, 2026

ProMIS Neurosciences to Present Data on ALS & Parkinsons Disease Programs at Alzheimer’s Disease/Parkinson’s Disease 2026 International Conference (AD/PD™)

Indeterminate GlobeNewswire

Mar. 18, 2026

Zymeworks Announces Presentations for Ziihera® (zanidatamab-hrii) at 2026 AACR Annual Meeting

Indeterminate GlobeNewswire

Mar. 18, 2026

Artelo Announces Third-Party Fully Funded Clinical Study Agreement to Evaluate ART27.13 in Glaucoma Patients

Indeterminate GlobeNewswire

Mar. 18, 2026

BriaCell to Present Positive Clinical Data for Bria-IMT™ and Preclinical Data for Next Generation Bria-OTS+™ Personalized Immunotherapy at the 2026 AACR Conference

Indeterminate GlobeNewswire

Mar. 18, 2026

InflaRx Announces Late-Breaker Oral Presentation on Vilobelimab Phase 3 Results in Pyoderma Gangrenosum at 2026 American Academy of Dermatology Annual Meeting

Indeterminate GlobeNewswire